UAE cancer diagnostics market is anticipated
to register growth with an impressive CAGR in the forecast period, 2023-2027,
on the account of rapidly growing cases of cancer. Majority of the cases of
cancer are of breast cancer, increasing instances of breast cancer among the
female population is alarming for the government. Government approaches with
advancing healthcare facilities to provide treatment and patient care to the
cancer patients is further driving the growth of the UAE cancer diagnostics
market in the upcoming five years.
Abnormal cell mitosis without the
complete cycle of meiosis forms a lump of abnormally growing number of cells.
These cells are termed as cancerous cells or tumor cells. Cancer diseases are
specifically defined by the abnormal cell growth in a particular organ or
system of the body. For example, lung cancer involves abnormal growth of the
lung cells forming a tumor inside the organ and hindering the functions of the
lungs.
Although there are multiple reasons for developing cancer, major reason
is the genetic mutation in human genome. Due to various factors like
environmental factors, natural genetic mutation, prolonged exposure to the
carcinogenic material, etc. can cause cancer. Diagnosis of the disease is a
huge challenge since the diagnosis is often at a later stage and treatment
becomes vey difficult, ultimately leading the patient to death.
Increasing Cancer Instances Demand
Advanced Diagnostics
United Arab Emirates possess a well
established healthcare industry. Technologically advanced procedures,
instruments, medical devices, kits & reagents for the advancement in the
diagnostic process is mandatory and drives the growth of the UAE cancer
diagnostics market in the upcoming five years. Cancer instances have been
rising in the country in recent years.
In the year 2020, 4807 new cancer cases
were discovered. Breast cancer held largest shares of the new cancer cases,
about 21.4% amounting to 1030 cases. Colorectum cancer, thyroid cancer,
leukemia, prostate cancer shares followed its lead accounting for 10.6%, 8.4%,
5.7%, and 5.6% new case shares in the year 2020. All other types of cancer
calculated together had 2320 new cases altogether.
Rising instances have also alarmed the
population regarding regular checkups, and routine tests to identify any
symptoms, to diagnose cancer early. Increasing demands for early diagnosis of
cancer and its severity along with higher demand for regular checkups and
routine tests are further supporting the growth of the UAE cancer diagnostics
market in the next five years.
Technological Advancements Drive Market
Growth
In the regions of Dubai number of cancer
diagnostics centers and hospitals dedicated for oncological treatment are
rapidly growing. Increasing infrastructures for the oncology diagnostics, and
treatment are also driving the growth of the UAE cancer diagnostics market in
the upcoming five years. These health centers invest actively in research and
development of the efficient cancer diagnostic kits and reagents, that can be
affordable as well as quick to determine the cancer cases.
Precision medicine in cancer diagnostics
uses biomarker testing. Previously identified genetic mapping known as cancer
biomarkers are utilized to look for the cancer causing genes, proteins, and
other substances. Using the method, oncologists are able to define a specific
treatment plan that is individualized and carries genomic information of the
cancer. The information also carries patient’s own genetics, their metabolic
profile, environment, and habits that aid the treatment process.
Click here to download the sample
Market Segmentation
The UAE cancer
diagnostics market is segmented by product, technology, application, end user, competitional
landscape, and regional distribution. Based
on product, the market is divided between consumable and instruments.
Consumable include antibodies, kits & reagents, probes, and others.
Instruments include pathology instruments, imaging instruments, and biopsy
instruments.
Technology segment of the market is further segmented into IVD
testing, imaging, and biopsy. By application, the market is bifurcated into breast
cancer, lung cancer, colorectal cancer, and others. Based on end user, the
market is fragmented into hospitals & clinics, diagnostic laboratories, and
others. The market analysis also studies the regional segmentation to devise
regional market segmentation, divided among Abu Dhabi region, Sharjah region, Dubai
region and the rest of UAE.
Company Profile
GE Healthcare FZE, Abbott Laboratories S
A, Roche Diagnostics Middle East FZCO, FUJIFILM Middle East FZE, Danaher Middle
East LLC, Agilent Technologies UAE, Hologic Inc. UAE, among others is a partial list of
major market players of the companies responsible for the growth of UAE cancer
diagnostics market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historical Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments covered
|
·
Product
·
Technology
·
Application
·
End User
|
|
Regional scope
|
Abu Dhabi region, Sharjah region, Dubai region and the rest of
UAE.
|
|
Key companies profiled
|
GE Healthcare FZE, Abbott Laboratories S A, Roche Diagnostics
Middle East FZCO, FUJIFILM Middle East FZE, Danaher Middle East LLC, Agilent
Technologies UAE, Hologic Inc. UAE
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, UAE cancer diagnostics market has been segmented into
following categories, in addition to the industry trends which have also been
detailed below:
- UAE Cancer Diagnostics Market, By Product:
- Consumable
- Antibodies
- Kits & Reagents
- Probes
- Others
- Instruments
- Pathology Instruments
- Imaging Instruments
- Biopsy Instruments
- UAE Cancer Diagnostics Market, By Technology:
- IVD Testing
- Imaging
- Biopsy
- UAE Cancer Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Others
- UAE Cancer Diagnostics Market, By End
User:
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
- UAE Cancer Diagnostics Market, By
Region:
o Abu Dhabi
o Sharjah
o Dubai
o Rest of UAE
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in UAE cancer diagnostics market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
UAE Cancer Diagnostics Market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]